Spliceosome-mediated trans-splicing: The therapeutic cut and paste

Journal of Investigative Dermatology

Volumn 132, Issue 8, 2012, Pages 1959-1966

  Wally, Verena ^a   Murauer, Eva M ^a   Bauer, Johann W ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; BLOOD CLOTTING FACTOR 8; CD40 LIGAND; COLLAGEN TYPE 7; CYTOKERATIN 14; DNA POLYMERASE; DYSTROPHIN; ENDOTOXIN; EXOTOXIN; MESSENGER RNA; MESSENGER RNA PRECURSOR; MICROTUBULE ASSOCIATED PROTEIN; PLECTIN; RIBOZYME; RNA; STREPTOLYSIN O; SURVIVAL MOTOR NEURON PROTEIN 1; SURVIVAL MOTOR NEURON PROTEIN 2; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALLELE; CELL DEATH; EXON; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LIBRARY; GENE MUTATION; GENE TECHNOLOGY; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MEDIATOR; MOLECULAR IMAGING; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPLICEOSOME; SPLICEOSOME MEDIATED RNA TRANS SPLICING; SQUAMOUS CELL CARCINOMA; SUICIDE GENE THERAPY; TRANS SPLICING; TRANSPOSON; WILD TYPE;

EID: 84863983970     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.101     Document Type: Note

References (55)

1. Aiuti A, Roncarolo MG (2009) Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematol Educ Prog 2009:682-9
2. Bhaumik S, Walls Z, Puttaraju M et al. (2004) Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing. Proc Natl Acad Sci USA 101:8693-8
3. Brown MP, Topham DJ, Sangster MY et al. (1998) Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 4:1253-60
4. Byun J, Lan N, Long M et al. (2003) Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. RNA 9:1254-63
5. Cao TY, Longley MA, Wang XJ et al. (2001) An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J Cell Biol 152:651-6
6. Chao HJ, Mansfield SG, Bartel RC et al. (2003) Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 9:1015-9
7. Coady TH, Baughan TD, Shababi M et al. (2008) Development of a single vector system that enhances trans-splicing of SMN2 transcripts. Plos One 3:e3468
8. Coady TH, Lorson CL (2010) Trans-splicingmediated improvement in a severe mouse model of spinal muscular atrophy. J Neurosci 30:126-30
9. Coady TH, Shababi M, Tullis GE et al. (2007) Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 premRNA splicing. Mol Ther 15:1471-8
10. Dallinger G, Puttaraju M, Mitchell LG et al. (2003) Development of spliceosomemediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases. Exp Dermatol 12:37-46
11. Davis RE, Hardwick C, Tavernier P et al. (1995) RNA trans-splicing in flatworms. Analysis of trans-spliced mRNAs and genes in the human parasite, Schistosoma mansoni. J Biol Chem 270:21813-9
12. Fiskaa T, Birgisdottir AB (2010) RNA reprogramming and repair based on trans-splicing group I ribozymes. New Biotechnol 27: 194-203
13. Flouriot G, Brand H, Seraphin B et al. (2002) Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene. J Biol Chem 277:26244-51
14. Friedmann T, Roblin R (1972) Gene therapy for human genetic disease? Science 175:949-55
15. Fritsch A, Spassov S, Elfert S et al. (2009) Dominant negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII. J Biol Chem 284:30248-56
16. Gruber C, Gratz IK, Murauer EM et al. (2011) Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells. Mol Cancer Ther 10: 233-41
17. Horne C, Young PJ (2009) Is RNA manipulation a viable therapy for spinal muscular atrophy? J Neurol Sci 287:27-31
18. Iwasaki R, Kiuchi H, Ihara M et al. (2009) Transsplicing as a novel method to rapidly produce antibody fusion proteins. Biochem Biophys Res Commun 384:316-21
19. Kastanos E, Hjiantoniou E, Phylactou LA (2004) Restoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes. Biochem Biophys Res Commun 322:930-4
20. Kierlin-Duncan MN, Sullenger BA (2007) Using 50-PTMs to repair mutant beta-globin transcripts. RNA 13:1317-27
21. Kikumori T, Cote GJ, Gagel RF (2001) Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy? Hum Gene Ther 12:1429-41
22. Koller U, Wally V, Mitchell LG et al. (2010) Improvement of RNA trans-splicing based gene correction using a RTM screening system. Hum Gene Ther 21:S1451 (abstr.)
23. Koller U, Wally V, Mitchell LG et al. (2011) A novel screening system improves genetic correction by internal exon replacement. Nuc Acids Res 39:e108
24. Liu XM, Luo MH, Zhang LN et al. (2005) Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells. Hum Gene Ther 16:1116-23
25. Lorain S, Peccate C, Le Hir M et al. (2010) Exon exchange approach to repair duchenne dystrophin transcripts. Plos One 5:e10894
26. Mansfield SG, Clark RH, Puttaraju M et al. (2003) 50 exon replacement and repair by spliceosome-mediated RNA trans-splicing. RNA 9:1290-7
27. Mavilio F, Pellegrini G, Ferrari S et al. (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397-402
28. Mayr E, Koller U, Murauer EM et al. (2011) A 50 trans-splicing gene therapy approach for dystrophic epidermolysis bullosa. J Invest Dermatol 131:S68 (abstr.)
29. Mitchell LG, McGarrity GJ (2005) Gene therapy progress and prospects: reprograming gene expression by trans-splicing. Gene Ther 12:1477-85
30. Morris KV (ed.) (2008) RNA and the Regulation of Gene Expression. Calista Academic Press: La Jolla, 228
31. Murauer EM, Gache Y, Gratz I et al. (2011) Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. J Invest Dermatol 131:74-83
32. Murauer EM, Gache Y, Larcher F et al. (2010) 30 trans-splicing repair of COL7A1 mutations in recessive dystrophic epidermolysis bullosa patients. J Invest Dermatol 130:S75 (abstr.)
33. Murphy WJ, Watkins KP, Agabian N (1986) Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing: evidence for trans splicing. Cell 47:517-25
34. Nakayama K, Pergolizzi RG, Crystal RG (2005) Gene transfer-mediated pre-mRNA segmental trans-splicing as a strategy to deliver intracellular toxins for cancer therapy. Cancer Res 65:254-63
35. Perumbeti A, Malik P (2010) Genetic correction of sickle cell anemia and beta-thalassemia: progress and new perspective. Scientific World Journal 10:644-54
36. Puttaraju M, DiPasquale J, Baker CC et al. (2001) Messenger RNA repair and restoration of protein function by spliceosomemediated RNA trans-splicing. Mol Ther 4: 105-14
37. Puttaraju M, Jamison SF, Mansfield SG et al. (1999) Spliceosome-mediated RNA transsplicing as a tool for gene therapy. Nat Biotechnol 17:246-52
38. Rodriguez-Martin T, Anthony K, Garcia-Blanco MA et al. (2009) Correction of tau missplicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA transsplicing. Hum Mol Genet 18:3266-73
39. Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG et al. (2005) Reprogramming of tau alternative splicing by spliceosomemediated RNA trans-splicing: implications for tauopathies. Proc Natl Acad Sci USA 102:15659-64
40. Schlesinger J, Arama D, Noy H et al. (2003) In-cell generation of antibody single-chain Fv transcripts by targeted RNA trans-splicing. J Immunol Meth 282:175-86
41. Shababi M, Glascock J, Lorson CL (2011) Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy. Hum Gene Ther 22: 135-44
42. Shababi M, Lorson CL (2011) Optimization of SMN trans-splicing through the analysis of SMN introns. J Mol Neurosci 46:459-69
43. Shin KS, Sullenger BA, Lee SW (2004) Ribozymemediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA. Mol Ther 10:365-72
44. Siomi H, Siomi MC (2009) On the road to reading the RNA-interference code. Nature 457: 396-404
45. Song Y, Lou HH, Boyer JL et al. (2009) Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum Gene Ther 20:267-81
46. Sullenger BA, Cech TR (1994) Ribozymemediated repair of defective mRNA by targeted, trans-splicing. Nature 371:619-22
47. Tahara M, Pergolizzi RG, Kobayashi H et al. (2004) Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency. Nat Med 10: 835-41
48. Walls ZF, Puttaraju M, Temple GF et al. (2008) A generalizable strategy for imaging premRNA levels in living subjects using spliceosome-mediated RNA trans-splicing. J Nucl Med 49:1146-54
49. Wally V, Brunner M, Lettner T et al. (2010) K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet 19:4715-25
50. Wally V, Klausegger A, Koller U et al. (2008) 50 trans-splicing repair of the PLEC1 gene. J Invest Dermatol 128:568-74
51. Wally V, Koller U, Bauer JW (2011) Highthroughput screening for highly functional RNA-trans-splicing molecules: correction of plectin in epidermolysis bullosa simplex. In: Plaseska-Karanfilska D (ed.) Genetic Disease. InTech Open Access Publisher: Rijeka
52. Wang J, Mansfield SG, Cote CA et al. (2009) Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo. Mol Ther 17:343-51
53. Werner NS, Windorffer R, Sternad P et al. (2004) Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits. Mol Biol Cell 15:990-1002
54. Yang YP, Walsh CE (2005) Spliceosome-mediated RNA trans-splicing. Mol Ther 12:1006-12
55. Zayed H, Xia L, Yerich A et al. (2007) Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery. Mol Ther 15:1273-9